The RNA delivery dilemma—lipid versus polymer nanoparticle platforms

dc.contributor.affiliation000000041762408X
dc.contributor.affiliationi3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Portugal, Porto, Porto, Portugal; INEB-Instituto Nacional de Engenharia Biomédica, Porto, Porto, Portugal; School of Engineering and Applied Science, Philadelphia, PA, United States; Penn Medicine, Philadelphia, PA, United States; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, United States; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, United States; Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, United States; Cardiovascular Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, United States; Institute for Regenerative Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, United States; Laboratory of Precision NanoMedicine, Tel Aviv University, Tel Aviv-Yafo, Tel Aviv District, Israel; Department of Materials Science and Engineering, Tel Aviv University, Tel Aviv-Yafo, Tel Aviv District, Israel; Tel Aviv University, Tel Aviv-Yafo, Tel Aviv District, Israel; Cancer Biology Research Center, Tel Aviv University, Tel Aviv-Yafo, Tel Aviv District, Israel; University of Strathclyde, Glasgow, Scotland, United Kingdom; Program in Genetic Drug Engineering, Department of Biomedical Engineering, Dallas, TX, United States; Department of Biochemistry, Harold C. Simmons Comprehensive Cancer Center, Dallas, Dallas, TX, United States; Centro Singular de Investigación en Medicina Molecular e Enfermidades Crónicas (CiMUS), Santiago de Compostela, A Coruña, Spain; Department of Pharmacology, Universidade de Santiago de Compostela, Santiago de Compostela, A Coruna, Spain; Universidade de Santiago de Compostela, Santiago de Compostela, A Coruna, Spain; IMDEA Nanociencia, Madrid, Madrid, Spain; Department of Pharmaceutics and Food Technology, Universidad Complutense de Madrid, Facultad de Farmacia, Madrid, Madrid, Spain; Institute of Industrial Pharmacy, Universidad Complutense de Madrid, Madrid, Madrid, Spainen
dc.contributor.authorMartins, C.
dc.contributor.authorMitchell, M.J.
dc.contributor.authorPeer, D.
dc.contributor.authorPerrie, Y.
dc.contributor.authorSiegwart, D.J.
dc.contributor.authorAlonso Fernández, M.J.
dc.contributor.authorAparicio-Blanco, J.
dc.date.accessioned2026-02-17T15:01:48Z
dc.date.available2026-02-17T15:01:48Z
dc.date.issued2026
dc.identifier.doi10.1007/s13346-026-02044-6
dc.identifier.urihttps://hdl.handle.net/20.500.12614/4172
dc.journal.titleDrug Delivery and Translational Researchen
dc.language.isoenen
dc.relation.projectIDTEMPC.M. acknowledges funding by FCT\u2014Funda\u00E7\u00E3o para a Ci\u00EAncia e a Tecnologia in the framework of the project COMPETE2030-FEDER-00683900. C.M. also acknowledges CEEC contract (2023.07049.CEECIND).
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España
dc.rights.accessRightsopen accessen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/
dc.titleThe RNA delivery dilemma—lipid versus polymer nanoparticle platformsen
dc.typeresearch articleen

Files

Collections